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Abstract 
This study investigates the use of high molecular weight polyethylene oxide (PEO WSR
coagulant) for the preparation of sustained release matrix tablets containing high dose,
highly water soluble drug, tramadol HCl. Proportion of PEO polymer, type of insoluble
filler, proportion of tramadol HCl, amount of drug in tablet, tablet diameter and compres-
sion pressure were recognized as critical formulation and process parameters and their
influence on drug release and tablet mechanical properties was evaluated. Percentages of
tramadol HCl released after 30 and 240 min were selected for evaluation of drug release,
while tensile strength was used as indicator of tablet mechanical properties. Only pro-
portion of tramadol HCl exhibits statistically significant effect on percentages of tramadol
HCl released after 30 and 240 min, with higher, wherein increasing of the tramadol HCl 
proportion increased its release rate among the evaluated variables in selected ranges. All
of the investigated factors exhibit statistically significant effect on tablets tensile strength,
with the largest influence of filler type. Tablets prepared with highly compressible filler 
(microcrystalline cellulose) exhibit higher tensile strength and therefore better mechanical
properties to those prepared with partially pregelatinized starch (starch 1500). 
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The usage of hydrophilic polymers, as the release 
rate control agents in matrix sustained release formul-
ations, has been considered as the simplest and most 
cost-effective method for preparation of extended rel-
ease solid dosage forms [1]. Numerous types of syn-
thetic and natural polymers have been established for 
formulating hydrophilic matrix tablets, such as hypro-
mellose, polyethylene oxide, hydroxypropylcellulose, 
etc. [2]. Polyethylene oxides (PEOs) are class of hydro-
philic nonionic linear polymers, commercially available 
in variable grades, with average molecular weight in 
range from 100000 to 8000000. They were introduced 
as alternative to cellulose derivatives, the most com-
monly used polymers in the formulation of extended 
release matrix tablets [3,4]. There are several impor-
tant features of PEO polymers that favor their wide 
application in the formulation of hydrophilic extended 
release matrix tablets, such as their physical and che-
mical stability, non-toxicity, insensitivity to the pH of 
the physiological fluids, good compressibility and high 
swelling ability [5]. In the previous studies, the high 
                                                                        
Correspondence: S.R. Ibrić, Faculty of Pharmacy, Department of 
Pharmaceutical Technology, Vojvode Stepe 450, 11221 Belgrade, 
Serbia. 
E-mail: svetlana.ibric@pharmacy.bg.ac.rs 
Paper received: 17 March, 2014 
Paper accepted: 22 September, 2014 
molecular weight PEOs have been successfully used in 
the preparation of sustained release matrix tablets by 
direct compression, containing either water soluble or 
insoluble drug [6,7]. Once in contact with water, the 
PEO matrix starts to swell due to formation of hydro-
gen bonds between polymeric chains and water. For-
mation of the hydrophilic gel layer is responsible for 
prolonged drug release [8]. Basic processes, which 
determine drug release from hydrophilic matrix tablets, 
are drug diffusion through the gel layer as well as 
erosion of the swollen gel layer [9]. Solubility of the 
drug has profound influence on the mechanism that 
determined drug release from matrix and should be 
considered in selecting proper type and grade of matrix 
polymer. Release of highly water soluble drug from 
hydrophilic matrix system is mainly controlled by the 
diffusion through the swollen gel layer, whereas rel-
ease of poorly soluble drug is dominantly controlled by 
the polymer erosion (relaxation) [10]. Tablet geometry 
has also profound influence on the drug release from 
diffusion-controlled systems and this has been studied 
in details by Siepmann et al. [11]. Thus, the effect of a 
tablet surface/tablet volume ratio (SA/Vol) on the drug 
release from hydrophilic matrices was investigated for 
hypromellose matrix tablets [12] and for hydroxypro-
pylcellulose matrix tablets [13].  
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In formulation of hydrophilic matrix tablets with 
high-dose, highly soluble drug, the two important 
issues, regarding selecting of proper matrix polymer, 
should be considered: the capability of polymer to 
prevent premature drug release, as well as ability to 
sustain drug release with predictable kinetics. Another 
important characteristic of matrix tablets should be 
acceptable mechanical properties in order to maintain 
tablet integrity during further processing, such as 
packaging and coating and application by the patient. 
Mechanical properties of powder mixtures and com-
pacts can be assessed through evaluation of compres-
sibility (solid fraction vs. compaction pressure), com-
pactibility (tensile strength vs. solid fraction) and tab-
letability (tensile strength vs. compaction pressure). 
Yang et al. have proved that under applied compres-
sion pressure the consolidation mechanism of PEO 
follows plastic deformation. However, characteristic 
viscoelastic behavior of PEOs with large axial expansion 
after compression results in production of low tensile 
strength tablets. According to these results it was sug-
gested that PEO polymers should be used with highly 
compactible excipients [14]. Comparison of the drug 
release, as well as mechanical characteristics between 
hypromellose 100000 mPa s and different high viscosity 
PEOs (Polyox WSR 1105, 301 and 303), was per-
formed on matrix tablets containing metformin HCl as a 
model drug. The results of this study proved lower tab-
letability of PEO in respect to HPMC [15]. Most of the 
studies that investigate mechanical characteristics of 
hydrophilic matrix tablets were conducted on either 
excenter tablet press or instrumented small rotary 
press. There are numerous advantages of using com-
paction simulator in comparison to conventional tablet 
presses. It offers studying of basic compaction mech-
anisms, evaluation of influence of process variables on 
tablet properties, determination of scale-up para-
meters, creating compaction data bank, and finger-
printing of new active pharmaceutical ingredients 
(APIs) or excipients [16]. Using of compaction simulator 
enables evaluation and comparison of powder mech-
anical properties in simulated production conditions. 
Mathematical equations can be used to describe com-
paction events and density-pressure relationships that 
predict the pressures required for achieving an opti-
mum compact density. This understanding has found 
active application in solving the analytical problems 
related to tableting, such as capping, lamination, pick-
ing, sticking, etc. Mathematical models, such as force-
time, force-distance, and die-wall force parameters are 
used to describe work of compaction, elasticity, plas-
ticity, and time dependent deformation behavior of 
pharmaceuticals. Parameters such as the bonding 
index, brittle fracture index and strain index can be 
used to predict compaction related problems [16].  
This study investigates using of high molecular 
weight PEO (Polyox WSR coagulant) for the preparation 
of sustained release matrix tablets with high dose, 
highly soluble model drug, tramadol HCl. Both drug 
release and tablets mechanical properties were recog-
nized as critical quality attributes of hydrophilic matrix 
tablets. Critical formulation (proportion of PEO poly-
mer, type of insoluble filler, proportion of tramadol 
HCl, amount of drug in tablet and tablet diameter) and 
process parameters (compression pressure) were sel-
ected in the study and the influence of these para-
meters on drug release and tablet mechanical proper-
ties was evaluated. Aim of this study was preliminary 
evaluation of selected variables on tablet quality attri-
butes, since all variables were varied on two levels 
through screening experimental design. 
EXPERIMENTAL 
Materials 
The following materials were used: polyethylene 
oxide (Polyox WSR coagulant, Dow Chemical Company, 
Midland, TX, USA), microcrystalline cellulose (Avicel PH 
102, FMC Biopolymer, USA), partially pregelatinized 
maize starch (Starch 1500, Colorcon, Dartford, Kent, 
UK), colloidal silicon dioxide (Aerosil 200 Pharma, 
Degussa), magnesium stearate (Mallinckrodt, St. Louis, 
MO, USA). Tramadol HCl (Hemofarm A.D., Vršac, Ser-
bia) was used as model of high dose, highly water sol-
uble drug. 
Experimental design 
In the first part, the experiments were conducted to 
evaluate the influence of formulation (proportion of 
PEO polymer, type of insoluble filler, proportion of 
tramadol HCl, amount of drug in tablet and tablet 
diameter) and process parameter (compression pres-
sure) on tramadol release. Percentage of drug release 
from matrix tablets after 30 and 240 min were selected 
as response variables. Experiments were performed 
according to 25–2 fractional factorial design, as pre-
sented in the Table 1.  
In order to eliminate influence of matrix tablets 
geometry on drug release, normalization of the per-
centage of drug released after 30 and 240 min, was 
performed by dividing obtained drug released percent-
age with surface area per volume ratio (SA/Vol) of 
tablets.  
In the second part of the study 23 full factorial 
design was used to evaluate the influence of the matrix 
polymer proportion, type of filler  and drug proportion 
on the tablet mechanical properties. Levels of inves-
tigated variables are presented in Table 1. Tensile 
strength (σt) was used as an indicator of tablets mech-
anical properties, enabling comparison of mechanical 
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properties of tablets with different dimensions. Tensile 









=  (1) 
where F is the crushing force, d is the tablet diameter 
and h is the tablet thickness. 
Tablets preparation 
Powder mixtures for compression were prepared by 
using Turbula® shaker-mixer (Glen Mills Inc., Clifton, NJ, 
USA). Tablets were compressed with direct compres-
sion method by using of PressterTM single station com-
pacting simulator (Metropolitan Computing Corpor-
ation, East Hanover, NJ, USA). Simulation of the rotary 
tablet press Korsch PH336 was used, with simulated die 
table speed of 30 rpm which conforms to 65000 tablets 
per hour and dwell time of 20 ms. Tablets were pre-
pared using punches with diameters of 7, 10 and 13 
mm, while tablet masses were 180, 360 and 720 mg, 
respectively, according to the experimental design. 
Compression pressure was calculated from the mea-
sured compaction force per cross-sectional area of tab-
lets. Tablets were compressed on different compaction 
pressures in the range of 100–500 MPa with simulation 
of the compaction profile of the Korch PH336 rotary 
tablet press. Tensile strength was calculated from mea-
sured hardness and tablet dimensions. Influence of the 
selected input variables on the tablet tensile strength 
was analyzed.  
Drug release testing 
Drug release test was performed using rotating 
basket apparatus (Erweka, Hausemmann, Germany) 
during 4 h (rotational speed 75 rpm, medium volume 
600 ml). Samples were taken after predefined time 
intervals: 30, 120, 180, 240, 360 and 480 min and the 
amount of dissolved tramadol HCl was determined 
spectrophotometrically at λ = 271 nm. The data col-
lected up to 240 min were selected for modeling of 
drug release. During the drug release testing, pH value 
of the medium was changed by adding buffer solutions 
as follows: in the first 30 min, pH 1.2; from 30–120 min, 
pH 2.3; from 120–180 min, pH 6.8; from 180–240 min, 
pH 7.2. Artificial gastric juice pH 1.2 was used as well as 
two buffer solutions for changing pH value during 
dissolution test: 
Buffer 1: K2HPO4, 63 g/ 100 ml (6 ml at 31 min). 
Buffer 2: NaOH 15 g/ 100 ml (6 ml at 121 min and 3 
ml at 181 min). 
Mechanical characterization of tablets 
Tablet hardness was measured using the 8M tablet 
hardness tester (Dr. Schleuniger Pharmatron, Thun, 
Switzerland) and tablet dimensions were measured 
with digital caliper. Tensile strength was calculated 
from dimensions of tablets and measured hardness, 
according to the Eq. (1). 
RESULTS AND DISCUSSION 
Evaluation of drug release from PEO matrices 
Tramadol HCl release profiles from PEO matrices 
(formulations F1–F8) are presented in Figure 1. 
Based on assumption that in hydrophilic matrices 
with high viscosity polymers and high water-soluble 
drug diffusion release mechanism is dominating in res-
pect to erosion, drug release process follows Higuchi’s 
model. There is linear relationship between drug rel-
ease and square-root-of-time (Figure 2) in the certain 
time intervals and it is related to geometrical character-
istics of matrix tablets. Calculated determination coef-
ficient values (R2) for all formulations were above 0.96, 
indicating good fitting to Higuchi model. 
Percentages of tramadol HCl released after 30 and 
240 min were selected as indicator of polymer ability to 
prevent premature drug release and enable sustained 
release of drug. Furthermore, both time points are 
within the interval in which drug release follows 
Higuchi's model. Normalized values of drug released 
percentage were used in order to eliminate influence 
Table 1. Experimental matrix according to 25-2 and 23 experimental design
Formulation Proportion of PEO polymer, % Filler type
a Proportion of tramadol HCl, % 
Compression 
pressure, MPa 




F1 25 Starch 1500 55.6 300 200 10 
F2 35 Starch 1500 55.6 150 100 7 
F3 25 Avicel PH 102 55.6 150 200 13 
F4 35 Avicel PH 102 55.6 300 100 7 
F5 25 Starch 1500 27.8 300 100 10 
F6 35 Starch 1500 27.8 150 200 13 
F7 25 Avicel PH 102 27.8 150 100 10 
F8 35 Avicel PH 102 27.8 300 200 13 
aStarch 1500 – partially pregelatinized maize starch; Avicel PH 102 – microcrystalline cellulose 
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Figure 1. Tramadol HCl release from PEO matrix tablets (formulation F1–F8). 
 
Figure 2. Tramadol HCl released from formulation F1-F8 per square root of time. 
of geometrical characteristics on drug release rate. 
Normalization was performed by dividing percentage of 
drug released with surface area per volume ratio 
(SA/Vol) of matrix tablets (Table 2). 
The influence of selected formulation and process 
parameters (proportion of PEO polymer, type of insol-
uble filler, proportion of tramadol HCl, amount of drug 
in tablet, tablet diameter and compression pressure) 
on normalized percentage of drug released at 30 and 
240 min was analyzed and presented on Figure 3. Pro-
portion of drug in tablet exhibits statistically significant 
effect on drug release after 30 min (p < 0.05). With Inc-
Table 2. Normalized values of Tramadol HCl released after 30 and 240 min 
Formulation Drug released after 30 min, % 
Drug released after 
240 min, % SA/Vol 
Normalized values of drug 
released after 30 min, % 
Normalized values of drug 
released after 240 min, %
F1 22.6 73.0 0.893 25.3 81.8 
F2 25.7 81.3 1.047 24.5 77.6 
F3 21.5 70.6 0.890 24.2 79.3 
F4 27.3 88.3 1.057 25.8 83.6 
F5 21.0 69.3 0.904 23.2 76.7 
F6 14.9 53.3 0.716 20.9 74.5 
F7 17.6 66.1 0.916 19.3 72.2 
F8 16.8 56.7 0.749 22.4 75.8 
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reasing proportion of drug in tablet, drug release inc-
reased. 
Influence of other formulation and process vari-
ables in selected range have no statistical significant 
influence on tramadol HCl release rate. For the drug 
release at later time point, 240 min, proportion of tra-
madol HCl in the formulation has statistical significant 
influence on drug release, too. 
Mechanical characterization of matrices with 
polyethylene oxide 
Full factorial design was performed in order to eval-
uate influence of input variables (proportion of poly-
mer, type of filler and proportion of tramadol HCl per 
tablet) on mechanical characteristics of matrix tablets. 
Due to different dimensions of tablets the tensile 
strength was used for evaluation of mechanical char-
acteristics of matrix tablets. 
Profiles of tensile strength versus compaction pres-
sure are presented in the Figure 4. 
Compression of tablet mixture was performed with 
compression force up to 40 kN, since the punch face 
diameter of 13 mm and compression pressure of about 
300 MPa compression force is near to maximum pos-
sible compression force which could be performed on 
compaction simulator. Tensile strengths of matrix tab-
 
API released after 30 min
 API released after 240 min
p=.05







Figure 3. Pareto chart of formulation and process parameters effects on drug released at 30 and 240 min from PEO matrix tablets. 
 
Figure 4. Profiles of tensile strength versus compaction pressure for powder mixtures with PEO WSR coagulant. 
N.D. NIKOLIĆ et al.: TRAMADOL HYDROCHLORIDE SUSTAINED RELEASE MATRIX TABLETS Hem. ind. 69 (5) 503–510 (2015) 
508 
lets on compaction pressures of 120 and 250 MPa were 
analyzed and compared as output variables (Table 3). 
Those values of tensile strength were extracted 
from trend lines of tabletability profiles (Figure 4). 
Value for compaction pressure of 120 MPa corresponds 
to values of tensile strength in ascending part of the 
tabletability profiles diagrams in all trials, while com-
pression pressure of 250 MPa is in the part where the 
profile reaches plateau. The higher values of tensile 
strength were obtained when Avicel PH 102 was used 
as filler comparing to the Starch 1500. Increase of tra-
madol HCl in tablet mixture negatively influences on 
tensile strength, while increase of PEO polymer in tab-
let mixture has positive impact on tensile strength. 
Pareto diagram of the influence of input variables 
on tensile strength (for compression pressure of 
approximately 120 and 250 MPa respectively) is pre-
sented in Figure 5. 
For PEO matrix tablets almost all input variables 
exhibit statistically significant effect on tablet tensile 
strength, with the largest influence of filler type. Mech-
anical properties of the matrix tablets with highly com-
pressible MCC as filler are significantly better compar-
ing to Starch 1500. 
Influence of proportions of polymer, filler and drug 
(comprising 100% of tablet) on tensile strength is pre-
sented in Figure 6a and b for Avicel PH 102 and Starch 
1500, respectively. 
Table 3. Tensile strengths of PEO matrix tablets 
Formulation Proportion of PEOpolymer, % Filler type
a Proportion of tramadol HCl, % 
Tensile strength 
120 MPa, N/cm2 
Tensile strength 
250 MPa, N/cm2 
F1 25 Starch 1500 55.6 44 71 
F2 35 Starch 1500 55.6 71 107 
F3 25 Avicel PH 102 55.6 82 105 
F4 35 Avicel PH 102 55.6 115 145 
F5 25 Starch 1500 27.8 25 53 
F6 35 Starch 1500 27.8 30 68 
F7 25 Avicel PH 102 27.8 160 212 
F8 35 Avicel PH 102 27.8 170 205 
aStarch 1500 – partially pregelatinized maize starch; Avicel PH 102 – microcrystalline cellulose 
 
Compression pressure 120 MPa
 Compression pressure 250 MPa
p=.05
Standardized Effect Estimate (Absolute Value)
Proportion of PEO polymer*Filler type
Proportion of PEO polymer*Proportion of tramadol HCl
Proportion of tramadol HCl
Proportion of PEO polymer
Filler type*Proportion of tramadol HCl
Filler type
 
Figure 5. Pareto chart of selected variables effects on tensile strength for PEO matrices for compression pressure of 120 and 250 MPa.







Figure 6. Influence of proportions of polymer, filler and drug 
(comprising 100% of tablet) on tensile strength: a) Avicel PH 
102 and b) Starch 1500. 
CONCLUSION 
In this study, the influence of critical formulation 
and process parameters on tramadol HCl release from 
PEO matrix tablets and tablet mechanical properties 
was evaluated using screening experimental design. 
Proportion of drug in tablet exhibits statistically sig-
nificant effect on drug release in the evaluated range. 
By increasing the proportion of drug in tablet, the drug 
release will be increased. Other formulation and pro-
cess variables in selected ranges have no statistical 
influence on tramadol HCl released rate. 
Regarding mechanical properties of tablets, type of 
filler has the most critical effect on the powder mixture 
tabletability. Mechanical properties of matrix tablets 
are significantly better with microcrystalline cellulose 
compared to partially pregelatinized starch. The highest 
tensile strength was obtained with Avicel PH 102 as 
filler and with higher percentage of polymer. Obtained 
results present preliminary evaluation of investigated 
variables on tablet quality attributes. Since all results 
were obtained from experiments where variables were 
varied on two levels, additional experimental work is 
needed in the future in order to establish mathematical 
model which will define influence of investigated vari-
ables on drug release and tablet mechanical properties. 
These findings could be useful in optimization of 
PEO sustained release matrix tablets with tramadol HCl, 
as high dose, highly soluble model drug. 
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ISPITIVANJE UTICAJA FAKTORA FORMULACIJE I PROCESA NA OSLOBAĐANJE TRAMADOL HIDROHLORIDA I 
MEHANIČKE KARAKTERISTIKE MATRIKS TABLETA SA PRODUŽENIM OSLOBAĐANJEM 
Nenad D. Nikolić1, Đorđe P. Medarević2, Svetlana R. Ibrić2, Zorica R. Đurić2 
1Hemofarm a.d., Beogradski drum b.b., Vršac, Srbija 
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(Naučni rad) 
U radu je ispitivan uticaj formulacijskih i procesnih promenljivih na brzinu
oslobađanja i mehaničke karakteristike matriks tableta izrađenih sa polietilen
oksidom velike molekulske mase (PEO WSR koagulant), kao matriks formirajućim
materijalom i visoko rastvoljivom lekovitom supstancom prisutnoj u velikoj dozi, 
tramadol hidrohloridom. Kao formulacijske promenljive varirane su: udeo poli-
etilen oksidnog polimera (25 ili 35%), vrsta nerastvornog sredstva za dopunjavanje
(mikrokristalna celuloza i parcijalno pregelirani skrob), udeo tramadol hidrohlo-
rida (27,8 i 55,6%), količina leka u tableti (100 ili 200 mg). Pritisak kompresije je
variran kao procesna promenljiva. Procenat tramadol hidrohlorida rastvoren 
nakon 30 i 240 min ispitivanja je izabran kao zavisno promenljiva za ispitivanje 
oslobađanja lekovite supstance, dok je zatezna čvrstoća izabrana kao zavisno
promenljiva koja je indikator mehaničkih karakteristika tableta. Izvedena su dva
seta eksperimenata, koji odgovaraju 25–2, odnosno 23 eksperimentalnom dizajnu. 
Tablete su izrađene na simulatoru kompakcije Prester. Simuliran je rad rotacione 
tablet prese Korch PH336, sa brzinom rotacije 30 rpm, što odgovara kapacitetu od
65000 tableta na sat. Ispitivanje uticaja faktora formulacije i procesa na 
oslobađanje tramadol hidrohlorida pokazalo je da se iz svih formulacija tramadol 
hidrohlorid oslobađa usporeno, linearnom kinetikom. Najveći uticaj na procenat 
oslobođenog leka imao je udeo leka u tableti. Sa povećanjem udela leka u tableti,
povećavao se i procenat oslobođenog leka u navedenim vremenskih intervalima.
Ostali isptivani faktori nisu imali značajan uticaj na brzinu oslobađanja. Ispitvanje
mehaničkih karakteristika tableta pokazalo je da na zateznu čvrstoću izrađenih
tableta najveći uticaj ima vrsta sredstva za dopunjavanje. Najveće vrednosti
zatezne čvrstoće su dobijene u slučaju kada je mikrokristalna celuloza korišćena
kao sredstvo za dopunjavanje, kao i kada je procenat polimera u tableti bio na
višem nivou. Analiza dobijenih rezultata omogućava pravilan izbor vrste i
koncentracije pomoćnih materija u formulaciji matriks tableta sa produženim
oslobađanjem izrađenih sa polietilen oksidnim polimerom i visoko rastvorljivom
lekovitom supstancom prisutnoj u velikoj dozi. 
  Ključne reči: Tramadol HCl • Matriks
tablete • PEO WSR koagulant • Osloba-
đanje lekovite supstance • Mehaničke
karakteristike tableta 
 
